Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.13
-0.09-0.45%
Pre-Market: 4:56 PM EDT
Comments
Loading...
Healthpeak Properties Analyst Ratings and Price Targets | NYSE:DOC | Benzinga
Healthpeak Properties Inc has a consensus price target of $21 based on the ratings of 20 analysts. The high is $28 issued by Deutsche Bank on October 21, 2024. The low is $14 issued by Truist Securities on December 22, 2023. The 3 most-recent analyst ratings were released by Scotiabank, Wedbush, and Baird on February 28, 2025, February 14, 2025, and February 11, 2025, respectively. With an average price target of $23.67 between Scotiabank, Wedbush, and Baird, there's an implied 17.57% upside for Healthpeak Properties Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Scotiabank
Wedbush
Baird
Wells Fargo
Mizuho
1calculated from analyst ratings
Analyst Ratings for Healthpeak Properties
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | Buy Now | 14.26% | Scotiabank | Nicholas Yulico56% | $24 → $23 | Maintains | Sector Outperform | Get Alert |
| 02/14/2025 | Buy Now | 19.23% | Wedbush | Richard Anderson64% | $24 → $27 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 19.23% | Baird | Amanda Sweitzer46% | $25 → $24 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | 9.29% | Wells Fargo | Connor Siversky69% | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 12/05/2024 | Buy Now | 19.23% | Mizuho | Vikram Malhotra57% | $25 → $24 | Maintains | Outperform | Get Alert |
| 11/04/2024 | Buy Now | 29.16% | RBC Capital | Michael Carroll64% | $25 → $26 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | 24.19% | Baird | Amanda Sweitzer46% | $24 → $25 | Maintains | Outperform | Get Alert |
| 10/21/2024 | Buy Now | 39.1% | Deutsche Bank | Omotayo Okusanya48% | $20 → $28 | Upgrade | Hold → Buy | Get Alert |
| 10/01/2024 | Buy Now | 14.26% | Wells Fargo | Connor Siversky69% | $22 → $23 | Assumes | Equal-Weight → Equal-Weight | Get Alert |
| 09/16/2024 | Buy Now | 29.16% | Evercore ISI Group | James Kammert29% | $25 → $26 | Maintains | Outperform | Get Alert |
| 09/09/2024 | Buy Now | 19.23% | Scotiabank | Nicholas Yulico56% | $23 → $24 | Maintains | Sector Outperform | Get Alert |
| 08/28/2024 | Buy Now | 24.19% | Evercore ISI Group | James Kammert29% | $24 → $25 | Maintains | Outperform | Get Alert |
| 08/22/2024 | Buy Now | 9.29% | Citigroup | Michael Bilerman59% | $20 → $22 | Maintains | Neutral | Get Alert |
| 07/30/2024 | Buy Now | 24.19% | RBC Capital | Michael Carroll64% | $22 → $25 | Maintains | Outperform | Get Alert |
| 07/29/2024 | Buy Now | 24.19% | Wedbush | Richard Anderson64% | $22 → $25 | Maintains | Outperform | Get Alert |
| 05/16/2024 | Buy Now | 14.26% | Scotiabank | Nicholas Yulico56% | $22 → $23 | Maintains | Sector Outperform | Get Alert |
| 05/16/2024 | Buy Now | 4.32% | JP Morgan | Michael Mueller55% | $19 → $21 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | Wedbush | Richard Anderson64% | — | Upgrade | Neutral → Outperform | Get Alert |
| 04/22/2024 | Buy Now | 9.29% | Mizuho | Vikram Malhotra57% | → $22 | Reinstates | → Buy | Get Alert |
| 04/10/2024 | Buy Now | 9.29% | RBC Capital | Michael Carroll64% | $21 → $22 | Maintains | Outperform | Get Alert |
| 04/01/2024 | Buy Now | 24.19% | B of A Securities | Joshua Dennerlein70% | $18 → $25 | Upgrade | Underperform → Buy | Get Alert |
| 03/25/2024 | Buy Now | -5.61% | Wells Fargo | Connor Siversky69% | → $19 | Reinstates | → Equal-Weight | Get Alert |
| 03/08/2024 | Buy Now | 4.32% | RBC Capital | Michael Carroll64% | → $21 | Reinstates | → Outperform | Get Alert |
| 01/05/2024 | Buy Now | — | Keybanc | Todd Thomas54% | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 01/02/2024 | Buy Now | -10.58% | Compass Point | Merrill Ross52% | $19 → $18 | Maintains | Buy | Get Alert |
| 12/22/2023 | Buy Now | -30.45% | Truist Securities | Michael Lewis67% | $15 → $14 | Maintains | Hold | Get Alert |
| 08/22/2023 | Buy Now | -30.45% | Citigroup | Michael Bilerman59% | $15 → $14 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | -25.48% | Truist Securities | Michael Lewis67% | → $15 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | Buy Now | -25.48% | Wells Fargo | Connor Siversky69% | $14 → $15 | Maintains | Underweight | Get Alert |
| 07/20/2023 | Buy Now | -27.97% | Morgan Stanley | Richard Hill55% | $14.5 → $14.5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/26/2023 | Buy Now | -23% | JMP Securities | Aaron Hecht34% | → $15.5 | Initiates | → Market Outperform | Get Alert |
| 04/20/2023 | Buy Now | -30.45% | Wells Fargo | Connor Siversky69% | → $14 | Initiates | → Underweight | Get Alert |
| 04/19/2023 | Buy Now | -30.45% | Wells Fargo | Connor Siversky69% | → $14 | Initiates | → Underweight | Get Alert |
| 03/29/2023 | Buy Now | -25.48% | Credit Suisse | Omotayo Okusanya48% | → $15 | Reiterates | → Neutral | Get Alert |
| 03/27/2023 | Buy Now | -5.61% | Compass Point | Floris Van Dijkum60% | $21 → $19 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | -25.48% | RBC Capital | Michael Carroll64% | $16 → $15 | Maintains | Sector Perform | Get Alert |
| 01/17/2023 | Buy Now | -10.58% | Barclays | Steve Valiquette62% | $20 → $18 | Maintains | Overweight | Get Alert |
| 12/14/2022 | Buy Now | -15.55% | Keybanc | Todd Thomas54% | → $17 | Upgrade | Sector Weight → Overweight | Get Alert |
| 11/01/2022 | Buy Now | -27.97% | Morgan Stanley | Richard Hill55% | $16.5 → $14.5 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | -15.55% | JP Morgan | Michael Mueller55% | → $17 | Initiates | → Neutral | Get Alert |
| 08/31/2022 | Buy Now | -18.03% | Morgan Stanley | Richard Hill55% | $16 → $16.5 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | Buy Now | -20.52% | Morgan Stanley | Richard Hill55% | $17.5 → $16 | Maintains | Equal-Weight | Get Alert |
| 07/11/2022 | Buy Now | -15.55% | Truist Securities | Michael Lewis67% | $18 → $17 | Maintains | Hold | Get Alert |
| 06/30/2022 | Buy Now | -0.65% | Jefferies | Jonathan Petersen61% | $21 → $20 | Maintains | Buy | Get Alert |
| 06/01/2022 | Buy Now | -13.07% | Morgan Stanley | Richard Hill55% | $18 → $17.5 | Maintains | Equal-Weight | Get Alert |
| 05/20/2022 | Buy Now | -5.61% | RBC Capital | Michael Carroll64% | $18 → $19 | Maintains | Sector Perform | Get Alert |
| 05/19/2022 | Buy Now | -10.58% | B of A Securities | Joshua Dennerlein70% | → $18 | Downgrade | Neutral → Underperform | Get Alert |
| 04/26/2022 | Buy Now | -0.65% | Barclays | Steve Valiquette62% | → $20 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Healthpeak Properties (DOC) stock?
The latest price target for Healthpeak Properties (NYSE:DOC) was reported by Scotiabank on February 28, 2025. The analyst firm set a price target for $23.00 expecting DOC to rise to within 12 months (a possible 14.26% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthpeak Properties (DOC)?
The latest analyst rating for Healthpeak Properties (NYSE:DOC) was provided by Scotiabank, and Healthpeak Properties maintained their sector outperform rating.
When was the last upgrade for Healthpeak Properties (DOC)?
The last upgrade for Healthpeak Properties Inc happened on October 21, 2024 when Deutsche Bank raised their price target to $28. Deutsche Bank previously had a hold for Healthpeak Properties Inc.
When was the last downgrade for Healthpeak Properties (DOC)?
The last downgrade for Healthpeak Properties Inc happened on January 5, 2024 when Keybanc changed their price target from N/A to N/A for Healthpeak Properties Inc.
When is the next analyst rating going to be posted or updated for Healthpeak Properties (DOC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthpeak Properties, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthpeak Properties was filed on February 28, 2025 so you should expect the next rating to be made available sometime around February 28, 2026.
Is the Analyst Rating Healthpeak Properties (DOC) correct?
While ratings are subjective and will change, the latest Healthpeak Properties (DOC) rating was a maintained with a price target of $24.00 to $23.00. The current price Healthpeak Properties (DOC) is trading at is $20.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.